Equal benefits to our residential courses, without the travel.
View Courses25th January 2022
On 12 January, regulators from around the world discussed the global regulatory response to the COVID-19 Omicron variant during a workshop, co-chaired by the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).